ROGER D. DANSEY - 20 Apr 2022 Form 4 Insider Report for Seagen Inc.

Role
Chief Medical Officer
Signature
By: /s/ Jennifer Prosba For: Roger D. Dansey
Issuer symbol
N/A
Transactions as of
20 Apr 2022
Net transactions value
-$207,565
Form type
4
Filing time
22 Apr 2022, 20:27:06 UTC
Previous filing
04 Feb 2022
Next filing
17 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGEN Common Stock Sale $113,579 -787 -1% $144.32 77,627 20 Apr 2022 Direct F1, F2
transaction SGEN Common Stock Sale $93,986 -652 -0.84% $144.15 76,975 21 Apr 2022 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
F3 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.